相似文献
1
Role of immunotherapy in metastatic renal cell cancer: past, present and future.
Ann Transl Med. 2019 Dec;7(Suppl 8):S349. doi: 10.21037/atm.2019.09.95.
2
The Past, Present and Future of Immunotherapy for Metastatic Renal Cell Carcinoma.
Anticancer Res. 2019 Jun;39(6):2683-2687. doi: 10.21873/anticanres.13393.
3
Current Management Options in Metastatic Renal Cell Cancer.
Oncol Rev. 2017 Jun 14;11(2):339. doi: 10.4081/oncol.2017.339.
4
Cytoreductive Nephrectomy Following Immunotherapy-Base Treatment in Metastatic Renal Cell Carcinoma: A Case Series and Review of Current Literature.
Curr Oncol. 2021 May 20;28(3):1921-1926. doi: 10.3390/curroncol28030178.
5
Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy.
Cancer J Sci Am. 1998 Mar-Apr;4(2):86-93.
6
Immunotherapy Is Changing First-Line Treatment of Metastatic Renal-Cell Carcinoma.
Clin Genitourin Cancer. 2019 Jun;17(3):e513-e521. doi: 10.1016/j.clgc.2019.01.017. Epub 2019 Feb 5.
7
Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy.
Target Oncol. 2021 Nov;16(6):813-821. doi: 10.1007/s11523-021-00852-z. Epub 2021 Nov 6.
8
Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
J Urol. 1999 Jul;162(1):46-50. doi: 10.1097/00005392-199907000-00012.
9
Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions.
Eur Urol. 2019 Jan;75(1):100-110. doi: 10.1016/j.eururo.2018.10.010. Epub 2018 Oct 13.
10
Current Landscape of Immunotherapy in Genitourinary Malignancies.
Adv Exp Med Biol. 2020;1244:107-147. doi: 10.1007/978-3-030-41008-7_6.
引用本文的文献
1
Immunotherapy and Immune Infiltration in Patients with Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis.
Genet Res (Camb). 2023 Apr 6;2023:3898610. doi: 10.1155/2023/3898610. eCollection 2023.
2
Rectal Metastasis of Renal Cell Carcinoma.
Intern Med. 2023 Apr 1;62(7):1103. doi: 10.2169/internalmedicine.0603-22. Epub 2022 Aug 20.
3
Enhanced Recovery After Surgery Protocol Optimizes Results and Cost of Laparoscopic Radical Nephrectomy.
Front Oncol. 2022 Apr 4;12:840363. doi: 10.3389/fonc.2022.840363. eCollection 2022.
4
Role of Immunomodulation of BCG Therapy on AML Remission.
Int Med Case Rep J. 2021 Feb 25;14:115-119. doi: 10.2147/IMCRJ.S296387. eCollection 2021.
5
Correlation of immune-related adverse events and response from immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.
J Thorac Dis. 2020 May;12(5):2706-2712. doi: 10.21037/jtd.2020.04.30.
本文引用的文献
1
A Phase I/II Study to Assess the Safety and Efficacy of Pazopanib and Pembrolizumab Combination Therapy in Patients with Advanced Renal Cell Carcinoma.
Clin Genitourin Cancer. 2021 Oct;19(5):434-446. doi: 10.1016/j.clgc.2021.04.007. Epub 2021 Apr 20.
2
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.
Lancet. 2019 Jun 15;393(10189):2404-2415. doi: 10.1016/S0140-6736(19)30723-8. Epub 2019 May 9.
3
Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
N Engl J Med. 2019 Mar 21;380(12):1103-1115. doi: 10.1056/NEJMoa1816047. Epub 2019 Feb 16.
4
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
N Engl J Med. 2019 Mar 21;380(12):1116-1127. doi: 10.1056/NEJMoa1816714. Epub 2019 Feb 16.
5
Disseminated herpes zoster following treatment with benralizumab.
Clin Respir J. 2019 Mar;13(3):189-191. doi: 10.1111/crj.12998. Epub 2019 Feb 17.
6
Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial.
Lancet Oncol. 2019 Feb;20(2):297-310. doi: 10.1016/S1470-2045(18)30778-2. Epub 2019 Jan 15.
7
Novel anticancers and dermatological adversities: old rivals but new challenges.
BMJ Case Rep. 2018 Dec 14;11(1):e227790. doi: 10.1136/bcr-2018-227790.
8
Anti PD-1 immunotherapy related interstitial lung disease presenting as respiratory failure - A review with case series.
Respir Med Case Rep. 2018 Nov 12;26:17-22. doi: 10.1016/j.rmcr.2018.11.005. eCollection 2019.
9
Intravascular Large B-Cell Lymphoma of the Kidney.
Kidney Int Rep. 2018 Aug 8;3(6):1501-1505. doi: 10.1016/j.ekir.2018.07.024. eCollection 2018 Nov.
10
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study.
J Immunother Cancer. 2018 Oct 22;6(1):109. doi: 10.1186/s40425-018-0420-0.
Zotero 插件